The Master of Science in Biotechnology and Management (MSBTM) program at Carnegie Mellon University’s H. John Heinz III College closed its doors at the end of the 2013-14 academic year. This decision was not made easily or lightly, but reflects the challenge of recruiting the quality and volume of students who meet the qualifications of this program. We are pleased that for six years Carnegie Mellon University imparted a world-class education at the intersection of biotechnology, technology, and management.
About the Program
Founded in 2007, the MSBTM program was a joint partnership between the Tepper School of Business, the Mellon College of Science, and Heinz College's School of Public Policy and Management. Since its inception, it made an important contribution to CMU's global partnerships and programming though international conferences, research collaborations, support for our global campuses, and student professional development programs across the globe. The MSBTM program focused on the specific skills associated with our healthcare system's manufacturing segment, broadly referred to as biotechnology management.
The MSBTM degree, a truly interdisciplinary program, imparted a balanced, in-depth emphasis on business and science. The program trained managers to simultaneously balance regulatory, scientific, and business issues as well as provide advice and facilitate communication between the company's chief executive officer and chief scientist.